Literature DB >> 20962632

Skeletal manifestations of systemic autoimmune diseases.

Diane L Kamen1, Jimmy D Alele.   

Abstract

PURPOSE OF REVIEW: There is an increased risk of osteoporotic fractures and osteonecrosis often at a young age among patients with certain systemic autoimmune diseases. The loss of bone mineral density and bone integrity seen with these diseases often cannot be explained by traditional risk factors alone. In this review, we focus on rheumatoid arthritis and systemic lupus erythematosus, two systemic autoimmune diseases in which skeletal manifestations have been well described. RECENT
FINDINGS: There is recent evidence that autoimmunity and its associated inflammation and vitamin D deficiency play key roles in the pathogenesis of adverse skeletal effects.
SUMMARY: Understanding these processes carries implications for the prevention and treatment of osteoporosis and osteonecrosis among patients with autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20962632     DOI: 10.1097/MED.0b013e328340533d

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  11 in total

1.  Bone geometry profiles in women with and without SLE.

Authors:  Jimmy D Alele; Diane L Kamen; Kelly J Hunt; Rosalind Ramsey-Goldman
Journal:  J Bone Miner Res       Date:  2011-11       Impact factor: 6.741

2.  Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.

Authors:  Michelle Wilkison; Katherine Gauss; Yanchao Ran; Steve Searles; David Taylor; Nicole Meissner
Journal:  Am J Pathol       Date:  2012-05-22       Impact factor: 4.307

3.  Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region.

Authors:  Tarek Carlos Salman-Monte; Vicenç Torrente-Segarra; M Almirall; Patricia Corzo; Sergi Mojal; Jordi Carbonell-Abelló
Journal:  Rheumatol Int       Date:  2016-05-27       Impact factor: 2.631

4.  Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score.

Authors:  Cynthia Wei-Sheng Lee; Chih-Hsin Muo; Ji-An Liang; Fung-Chang Sung; Chung-Y Hsu; Chia-Hung Kao
Journal:  Endocrine       Date:  2015-10-01       Impact factor: 3.633

5.  Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.

Authors:  Valentina Camozzi; Corrado Betterle; Anna Chiara Frigo; Veronica Zaccariotto; Martina Zaninotto; Erica De Caneva; Paola Lucato; Walter Gomiero; Silvia Garelli; Chiara Sabbadin; Monica Salvà; Miriam Dalla Costa; Marco Boscaro; Giovanni Luisetto
Journal:  Endocrine       Date:  2017-08-09       Impact factor: 3.633

6.  Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

Authors:  A Carr; B Grund; J Neuhaus; A Schwartz; J I Bernardino; D White; S Badel-Faesen; A Avihingsanon; K Ensrud; J Hoy
Journal:  HIV Med       Date:  2015-04       Impact factor: 3.180

7.  A CD40 variant is associated with systemic bone loss among patients with rheumatoid arthritis.

Authors:  Rim Sghiri; Hana Benhassine; Khadija Baccouche; Meriem Ghozzi; Sarra Jriri; Zahid Shakoor; Adel Almogren; Foued Slama; Nadia Idriss; Zeineb Benlamine; Elyes Bouajina; Ramzi Zemni
Journal:  Clin Rheumatol       Date:  2022-02-02       Impact factor: 2.980

8.  Lung-Specific Risk Factors Associated With Incident Hip Fracture in Current and Former Smokers.

Authors:  Jessica Bon; Seyed Mehdi Nouraie; Kenneth J Smith; Mark T Dransfield; Merry-Lynn McDonald; Eric A Hoffman; John D Newell; Alejandro P Comellas; Punam K Saha; Russell P Bowler; Elizabeth A Regan
Journal:  J Bone Miner Res       Date:  2020-08-04       Impact factor: 6.741

Review 9.  Cortical remodeling during menopause, rheumatoid arthritis, glucocorticoid and bisphosphonate therapy.

Authors:  Daniel Aeberli; Georg Schett
Journal:  Arthritis Res Ther       Date:  2013-03-21       Impact factor: 5.156

10.  Potential benefits of vitamin D for patients with systemic lupus erythematosus.

Authors:  Abha Singh; Diane L Kamen
Journal:  Dermatoendocrinol       Date:  2012-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.